Immunome (IMNM) Times Interest Earned (2019 - 2026)
Immunome's (IMNM) quarterly Times Interest Earned came in at -$0.32 in Q1 2026, up 99.81% YoY from -$0.16 in Q1 2025, and up 100.0% on a QoQ basis from -$14572.2 in Q4 2025.
Immunome (IMNM) Times Interest Earned (2019 - 2026) Analysis & Trends
Immunome (IMNM) has 8 years of Times Interest Earned data on file, last reported at -$0.32 in Q1 2026.
- Quarterly Times Interest Earned rose 99.81% year-over-year to -$0.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.29 (up 99.57% YoY) and the FY2025 annual result came in at -$1.24, up 56.71% from the prior year.
- Times Interest Earned rose to -$0.32 in Q1 2026, from -$14572.2 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.32 in Q1 2026 to a low of -$14572.2 in Q4 2025.
- A 5-year average of -$1062.9 and a median of -$4.96 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned sank 5624.73% — and 2026, when it jumped 99.81%.
- Tracing IMNM's Times Interest Earned over 5 years: stood at -$26.67 in 2022, then slumped by 5624.73% to -$1526.7 in 2023, then jumped by 81.88% to -$276.57 in 2024, then slumped by 5168.96% to -$14572.2 in 2025, then jumped by 100.0% to -$0.32 in 2026.
- The last three Times Interest Earned figures came in at -$0.32 (Q1 2026), -$14572.2 (Q4 2025), and -$1.44 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Immunome | 3.09 Bn | 2.57 Bn | - | -0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.46 |
| Mar 31, 2026 | -0.32 |
| Dec 31, 2025 | -14,572.20 |
| Sep 30, 2025 | -1.44 |
| Jun 30, 2025 | -1.95 |
| Mar 31, 2025 | -169.08 |
| Dec 31, 2024 | -276.57 |
| Sep 30, 2024 | -0.77 |
| Jun 30, 2024 | -0.87 |
| Mar 31, 2024 | -1,322.99 |
| Dec 31, 2023 | -1,526.66 |
| Sep 30, 2023 | -0.41 |
| Jun 30, 2023 | -0.56 |
| Mar 31, 2023 | -44.71 |
| Dec 31, 2022 | -26.67 |
| Sep 30, 2022 | -2.51 |
| Jun 30, 2022 | -4.96 |
| Mar 31, 2022 | -116.54 |
| Dec 31, 2021 | 91.21 |
| Jun 30, 2021 | -0.28 |